220 related articles for article (PubMed ID: 16164632)
1. Evidence linking glycated albumin to altered glomerular nephrin and VEGF expression, proteinuria, and diabetic nephropathy.
Cohen MP; Chen S; Ziyadeh FN; Shea E; Hud EA; Lautenslager GT; Shearman CW
Kidney Int; 2005 Oct; 68(4):1554-61. PubMed ID: 16164632
[TBL] [Abstract][Full Text] [Related]
2. Inhibiting albumin glycation in vivo ameliorates glomerular overexpression of TGF-beta1.
Cohen MP; Ziyadeh FN; Hong SW; Shearman CW; Hud E; Lautenslager GT; Iglesias-de la Cruz MC; Chen S
Kidney Int; 2002 Jun; 61(6):2025-32. PubMed ID: 12028443
[TBL] [Abstract][Full Text] [Related]
3. Inhibiting albumin glycation attenuates dysregulation of VEGFR-1 and collagen IV subchain production and the development of renal insufficiency.
Cohen MP; Lautenslager GT; Hud E; Shea E; Wang A; Chen S; Shearman CW
Am J Physiol Renal Physiol; 2007 Feb; 292(2):F789-95. PubMed ID: 17018845
[TBL] [Abstract][Full Text] [Related]
4. Normalizing glycated albumin reduces increased urinary collagen IV and prevents renal insufficiency in diabetic db/db mice.
Cohen MP; Hud E; Shea E; Shearman CW
Metabolism; 2002 Jul; 51(7):901-5. PubMed ID: 12077739
[TBL] [Abstract][Full Text] [Related]
5. Prevention of diabetic nephropathy in db/db mice with glycated albumin antagonists. A novel treatment strategy.
Cohen MP; Sharma K; Jin Y; Hud E; Wu VY; Tomaszewski J; Ziyadeh FN
J Clin Invest; 1995 May; 95(5):2338-45. PubMed ID: 7738197
[TBL] [Abstract][Full Text] [Related]
6. Inhibiting albumin glycation ameliorates diabetic nephropathy in the db/db mouse.
Cohen MP; Masson N; Hud E; Ziyadeh F; Han DC; Clements RS
Exp Nephrol; 2000; 8(3):135-43. PubMed ID: 10810230
[TBL] [Abstract][Full Text] [Related]
7. Glycated albumin stimulates TGF-beta 1 production and protein kinase C activity in glomerular endothelial cells.
Chen S; Cohen MP; Lautenslager GT; Shearman CW; Ziyadeh FN
Kidney Int; 2001 Feb; 59(2):673-81. PubMed ID: 11168949
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.
Ziyadeh FN; Wolf G
Curr Diabetes Rev; 2008 Feb; 4(1):39-45. PubMed ID: 18220694
[TBL] [Abstract][Full Text] [Related]
9. Effects of high glucose and TGF-beta1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes.
Iglesias-de la Cruz MC; Ziyadeh FN; Isono M; Kouahou M; Han DC; Kalluri R; Mundel P; Chen S
Kidney Int; 2002 Sep; 62(3):901-13. PubMed ID: 12164872
[TBL] [Abstract][Full Text] [Related]
10. Amelioration of diabetic nephropathy by treatment with monoclonal antibodies against glycated albumin.
Cohen MP; Hud E; Wu VY
Kidney Int; 1994 Jun; 45(6):1673-9. PubMed ID: 7933815
[TBL] [Abstract][Full Text] [Related]
11. Amadori-glycated albumin in diabetic nephropathy: pathophysiologic connections.
Chen S; Cohen MP; Ziyadeh FN
Kidney Int Suppl; 2000 Sep; 77():S40-4. PubMed ID: 10997689
[TBL] [Abstract][Full Text] [Related]
12. Inducible overexpression of sFlt-1 in podocytes ameliorates glomerulopathy in diabetic mice.
Ku CH; White KE; Dei Cas A; Hayward A; Webster Z; Bilous R; Marshall S; Viberti G; Gnudi L
Diabetes; 2008 Oct; 57(10):2824-33. PubMed ID: 18647955
[TBL] [Abstract][Full Text] [Related]
13. p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.
Wolf G; Schanze A; Stahl RA; Shankland SJ; Amann K
Kidney Int; 2005 Oct; 68(4):1583-9. PubMed ID: 16164635
[TBL] [Abstract][Full Text] [Related]
14. The Ethyl Acetate Extract of
Lin CH; Shih CC
Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928391
[TBL] [Abstract][Full Text] [Related]
15. Deletion of protein kinase C-beta isoform in vivo reduces renal hypertrophy but not albuminuria in the streptozotocin-induced diabetic mouse model.
Meier M; Park JK; Overheu D; Kirsch T; Lindschau C; Gueler F; Leitges M; Menne J; Haller H
Diabetes; 2007 Feb; 56(2):346-54. PubMed ID: 17259378
[TBL] [Abstract][Full Text] [Related]
16. Glycated albumin stimulates fibronectin gene expression in glomerular mesangial cells: involvement of the transforming growth factor-beta system.
Ziyadeh FN; Han DC; Cohen JA; Guo J; Cohen MP
Kidney Int; 1998 Mar; 53(3):631-8. PubMed ID: 9507208
[TBL] [Abstract][Full Text] [Related]
17. Role of Amadori-modified nonenzymatically glycated serum proteins in the pathogenesis of diabetic nephropathy.
Cohen MP; Ziyadeh FN
J Am Soc Nephrol; 1996 Feb; 7(2):183-90. PubMed ID: 8785386
[TBL] [Abstract][Full Text] [Related]
18. Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model.
Ichinose K; Maeshima Y; Yamamoto Y; Kitayama H; Takazawa Y; Hirokoshi K; Sugiyama H; Yamasaki Y; Eguchi K; Makino H
Diabetes; 2005 Oct; 54(10):2891-903. PubMed ID: 16186390
[TBL] [Abstract][Full Text] [Related]
19. Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli.
Wahab NA; Schaefer L; Weston BS; Yiannikouris O; Wright A; Babelova A; Schaefer R; Mason RM
Diabetologia; 2005 Dec; 48(12):2650-60. PubMed ID: 16270194
[TBL] [Abstract][Full Text] [Related]
20. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes.
Koya D; Haneda M; Nakagawa H; Isshiki K; Sato H; Maeda S; Sugimoto T; Yasuda H; Kashiwagi A; Ways DK; King GL; Kikkawa R
FASEB J; 2000 Mar; 14(3):439-47. PubMed ID: 10698958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
